Organovo Holdings, Inc. (NASDAQ: ONVO) presenting the first data showing survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into animal models. This data is being presented at the TERMIS-Americas Meeting in San Diego.
Organovo CEO Keith Murphy came to the Q2 (FY 2017) analyst and investor call knowing that he would be on the receiving end of some potentially hostile questions. During October shares in the 3D bio-printing company lost almost one third of their value after the company embarked on a new round of equity financing.
To get content containing either thought or leadership enter:
To get content containing both thought and leadership enter:
To get content containing the expression thought leadership enter:
You can enter several keywords and you can refine them whenever you want. Our suggestion engine uses more signals but entering a few keywords here will rapidly give you great content to curate.
Organovo Holdings, Inc. (NASDAQ: ONVO) presenting the first data showing survival and sustained functionality of its 3D bioprinted human liver tissue when implanted into animal models. This data is being presented at the TERMIS-Americas Meeting in San Diego.